Unfortunately you've used all of your gifts this month. Your counter will reset on the first day of next month.
Boehringer Ingelheim has opened another front in its attack on chronic kidney disease (CKD), offering Rectify Pharmaceuticals up to $448 million to partner on a preclinical program. The alliance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback